Middle East logistics players reportedly eye potential of DB Schenker takeover
Move aside, DSV? More than 20 bidders have reportedly expressed interest in buying DB Schenker, ...
– Extensive cooperation across warehousing, domestic distribution, international transports and logistics
– In support of Chinese pharma customers’ access to international markets, leveraging Kuehne+Nagel’s global pharma network
– Further strengthens Kuehne+Nagel’s presence in China
Kuehne+Nagel announces a strategic partnership with Jointown, China’s largest non-state-owned pharmaceutical distribution company, to accelerate its footprint in pharma and healthcare logistics in China.
As one of the leading logistics providers in the world, Kuehne+Nagel has been especially focused on developing pharma & healthcare expertise for the past decade. The partnership with Jointown now affords access to their fully GxP-compliant, in-country storage and distribution network, enabling Kuehne+Nagel to comply with the highly-regulated Chinese pharma & healthcare sector.
“We are pleased to be partnering with Jointown. Our cooperation perfectly meets the demands of our global clientele by enabling seamless supply chain coverage connecting China. This will enable us to accelerate our growth in the pharma and healthcare sector in China,” says Siewloong Wong, President of Kuehne+Nagel Asia Pacific.
Zhang Qingsong, General Manager of the logistics business unit of Jointown Pharmaceutical Group, adds: “Partnering with Kuehne+Nagel will provide Jointown’s customers access to the international market through their global GxP certified air, sea and overseas contract logistics operations. We will now be able to expand our business in overseas markets at a much faster pace and benefit from the partnership in a sustainable way.”
The full press release can be found here.